Drugs for Neglected Diseases initiative (DNDi) / dndi_transparency-activities
Dynamic Portfolio Unit
CH-FDJP-CHE110141200-190
EUR 6.04mdeclared budget
EUR 4.14mdisbursed and spent, 545 of 545 transactions
Implementationstatus
31 Dec 2028planned end
Budget over time
- Reporting organisation
- Drugs for Neglected Diseases initiative (DNDi)
- Start
- 01 Jan 2003 (planned)
- Countries
- —
- Sectors
- Health policy and administrative management (12110) 10%; Medical services (12191) 10%; Basic health infrastructure (12230) 10%; Infectious disease control (12250) 50%; Health education (12261) 15%; Health personnel development (12281) 5%; 121 · OECD DAC 3-digit 20%; 122 · OECD DAC 3-digit 80%; 3 · SDG goal 100%; 3.3 · SDG target 100%; 3.3.5 Number of people requiring interventions against neglected tropical diseases · SDG indicator 100%
- Funded by
- Drugs for Neglected Diseases initiative
- Participating
- Drugs for Neglected Diseases initiative (funding)
- Versions seen
- 2 since 26 Sept 2026 · last checked 2026-10-03 02:26 UTC
Changes
- 2026-10-03Budget changed+1 more
Budget EUR 4.63m → EUR 6.04m (+30.4%)
- Transactions added: 120 transactions added, EUR 929k
Dynamic Portfolio Unit · compare 0fbd0f94 → 795bcf10
Budgets
| Period | Type | Value | Record |
|---|---|---|---|
| 2019-01-01 → 2019-12-31 | revised, indicative | EUR 330k | new since 02 Oct 2026 |
| 2020-01-01 → 2020-12-31 | revised, indicative | EUR 659k | new since 02 Oct 2026 |
| 2018-01-01 → 2018-12-31 | revised, indicative | EUR 266k | new since 02 Oct 2026 |
| 2021-01-01 → 2021-12-31 | revised, indicative | EUR 652k | new since 02 Oct 2026 |
| 2022-01-01 → 2022-12-31 | revised, indicative | EUR 565k | new since 02 Oct 2026 |
| 2023-01-01 → 2023-12-31 | revised, indicative | EUR 1.15m | new since 02 Oct 2026 |
| 2024-01-01 → 2024-12-31 | revised, indicative | EUR 1.00m | new since 02 Oct 2026 |
| 2025-01-01 → 2025-12-31 | revised, indicative | EUR 1.41m | new since 02 Oct 2026 |
| 2019-01-01 → 2019-12-31 | original | EUR 330k | superseded, last seen 02 Oct 2026 |
| 2020-01-01 → 2020-12-31 | original | EUR 659k | superseded, last seen 02 Oct 2026 |
| 2018-01-01 → 2018-12-31 | original | EUR 266k | superseded, last seen 02 Oct 2026 |
| 2021-01-01 → 2021-12-31 | original | EUR 652k | superseded, last seen 02 Oct 2026 |
| 2022-01-01 → 2022-12-31 | original | EUR 565k | superseded, last seen 02 Oct 2026 |
| 2023-01-01 → 2023-12-31 | original | EUR 1.15m | superseded, last seen 02 Oct 2026 |
| 2024-01-01 → 2024-12-31 | original | EUR 1.00m | superseded, last seen 02 Oct 2026 |
Transactions
| Date | Type | Value | To | Note | Record |
|---|---|---|---|---|---|
| 2024-12-31 | Expenditure | EUR 1,410 | Drugs for Neglected Diseases initiative | Expenses - 190-2412-6-KE-GB-GOV-1 | new |
| 2024-12-31 | Expenditure | EUR -56 | Drugs for Neglected Diseases initiative | Expenses - 190-2412-1-MY | new |
| 2024-12-31 | Expenditure | EUR 230 | Drugs for Neglected Diseases initiative | Expenses - 190-2412-1-US | new |
| 2024-12-31 | Expenditure | EUR 8,613 | Drugs for Neglected Diseases initiative | Expenses - 190-2412-2-US | new |
| 2024-12-31 | Expenditure | EUR 3,048 | Drugs for Neglected Diseases initiative | Expenses - 190-2412-3-US-GB-GOV-1 | new |
| 2018-01-31 | Expenditure | EUR 258 | CH-FDJP-CHE110141200 | Expenses - 190-1801-1-CH | |
| 2018-01-31 | Expenditure | EUR 612 | CH-FDJP-CHE110141200 | Expenses - 190-1801-1-CH-CH-4 | |
| 2018-01-31 | Expenditure | EUR 2,636 | CH-FDJP-CHE110141200 | Expenses - 190-1801-1-CH-GB-GOV-1 | |
| 2018-01-31 | Expenditure | EUR 737 | CH-FDJP-CHE110141200 | Expenses - 190-1801-1-FR-GB-GOV-1 | |
| 2018-01-31 | Expenditure | EUR 59 | CH-FDJP-CHE110141200 | Expenses - 190-1801-1-GB-CH-4 | |
| 2018-02-28 | Expenditure | EUR 155 | CH-FDJP-CHE110141200 | Expenses - 190-1802-1-CH-CH-4 | |
| 2018-02-28 | Expenditure | EUR 12k | CH-FDJP-CHE110141200 | Expenses - 190-1802-1-CH-GB-GOV-1 | |
| 2018-02-28 | Expenditure | EUR 2,247 | CH-FDJP-CHE110141200 | Expenses - 190-1802-1-FR-GB-GOV-1 | |
| 2018-02-28 | Expenditure | EUR 464 | CH-FDJP-CHE110141200 | Expenses - 190-1802-2-CH-GB-GOV-1 | |
| 2018-03-31 | Expenditure | EUR 12k | CH-FDJP-CHE110141200 | Expenses - 190-1803-1-CH-GB-GOV-1 | |
| 2018-04-30 | Expenditure | EUR 17k | CH-FDJP-CHE110141200 | Expenses - 190-1804-1-CH-GB-GOV-1 | |
| 2018-04-30 | Expenditure | EUR 517 | CH-FDJP-CHE110141200 | Expenses - 190-1804-1-FR-GB-GOV-1 | |
| 2018-05-31 | Expenditure | EUR 11k | CH-FDJP-CHE110141200 | Expenses - 190-1805-1-CH-GB-GOV-1 | |
| 2018-05-31 | Expenditure | EUR 332 | CH-FDJP-CHE110141200 | Expenses - 190-1805-1-FR-GB-GOV-1 | |
| 2018-06-30 | Expenditure | EUR 12k | CH-FDJP-CHE110141200 | Expenses - 190-1806-1-CH-GB-GOV-1 | |
| 2018-06-30 | Expenditure | EUR 42 | CH-FDJP-CHE110141200 | Expenses - 190-1806-1-KE-CH-4 | |
| 2018-07-31 | Expenditure | EUR 217 | CH-FDJP-CHE110141200 | Expenses - 190-1807-1-CH-CH-4 | |
| 2018-07-31 | Expenditure | EUR 12k | CH-FDJP-CHE110141200 | Expenses - 190-1807-1-CH-GB-GOV-1 | |
| 2018-08-31 | Expenditure | EUR 12k | CH-FDJP-CHE110141200 | Expenses - 190-1808-1-CH-GB-GOV-1 | |
| 2018-09-30 | Expenditure | EUR 14k | CH-FDJP-CHE110141200 | Expenses - 190-1809-1-CH-GB-GOV-1 | |
| 2018-09-30 | Expenditure | EUR 750 | CH-FDJP-CHE110141200 | Expenses - 190-1809-1-FR-GB-GOV-1 | |
| 2018-10-31 | Expenditure | EUR 12k | CH-FDJP-CHE110141200 | Expenses - 190-1810-1-CH-GB-GOV-1 | |
| 2018-10-31 | Expenditure | EUR 3,448 | CH-FDJP-CHE110141200 | Expenses - 190-1810-1-FR-GB-GOV-1 | |
| 2018-10-31 | Expenditure | EUR 215 | CH-FDJP-CHE110141200 | Expenses - 190-1810-1-UG-GB-GOV-1 | |
| 2018-10-31 | Expenditure | EUR 1,242 | CH-FDJP-CHE110141200 | Expenses - 190-1810-1-US-GB-GOV-1 | |
| 2018-11-30 | Expenditure | EUR 13k | CH-FDJP-CHE110141200 | Expenses - 190-1811-1-CH-GB-GOV-1 | |
| 2018-11-30 | Expenditure | EUR 394 | CH-FDJP-CHE110141200 | Expenses - 190-1811-1-FR-GB-GOV-1 | |
| 2018-12-31 | Expenditure | EUR 5,000 | CH-FDJP-CHE110141200 | Expenses - 190-1812-1-CH-CH-4 | |
| 2018-12-31 | Expenditure | EUR 39k | CH-FDJP-CHE110141200 | Expenses - 190-1812-1-CH-GB-GOV-1 | |
| 2018-12-31 | Expenditure | EUR 5,000 | CH-FDJP-CHE110141200 | Expenses - 190-1812-1-DE-GB-GOV-1 | |
| 2019-01-31 | Expenditure | EUR 3,521 | CH-FDJP-CHE110141200 | Expenses - 190-1901-1-CH | |
| 2019-01-31 | Expenditure | EUR 500 | CH-FDJP-CHE110141200 | Expenses - 190-1901-1-CH-CH-4 | |
| 2019-01-31 | Expenditure | EUR -7,572 | CH-FDJP-CHE110141200 | Expenses - 190-1901-1-CH-GB-GOV-1 | |
| 2019-01-31 | Expenditure | EUR 4,875 | CH-FDJP-CHE110141200 | Expenses - 190-1901-1-DE-CH-4 | |
| 2019-01-31 | Expenditure | EUR 582 | CH-FDJP-CHE110141200 | Expenses - 190-1901-2-CH-GB-GOV-1 | |
| 2019-02-28 | Expenditure | EUR 17k | CH-FDJP-CHE110141200 | Expenses - 190-1902-1-CH | |
| 2019-02-28 | Expenditure | EUR 28k | CH-FDJP-CHE110141200 | Expenses - 190-1902-1-CH-CH-4 | |
| 2019-02-28 | Expenditure | EUR -31k | CH-FDJP-CHE110141200 | Expenses - 190-1902-1-CH-GB-GOV-1 | |
| 2019-02-28 | Expenditure | EUR 3,000 | CH-FDJP-CHE110141200 | Expenses - 190-1902-1-DE-GB-GOV-1 | |
| 2019-02-28 | Expenditure | EUR 29k | CH-FDJP-CHE110141200 | Expenses - 190-1902-1-SE-CH-4 | |
| 2019-02-28 | Expenditure | EUR 29k | CH-FDJP-CHE110141200 | Expenses - 190-1902-1-SE-GB-GOV-1 | |
| 2019-02-28 | Expenditure | EUR 686 | CH-FDJP-CHE110141200 | Expenses - 190-1902-2-CH-GB-GOV-1 | |
| 2019-03-31 | Expenditure | EUR 16k | CH-FDJP-CHE110141200 | Expenses - 190-1903-1-CH | |
| 2019-03-31 | Expenditure | EUR 1,364 | CH-FDJP-CHE110141200 | Expenses - 190-1903-1-CH-CH-4 | |
| 2019-03-31 | Expenditure | EUR 805 | CH-FDJP-CHE110141200 | Expenses - 190-1903-1-CH-GB-GOV-1 | |
| 2019-03-31 | Expenditure | EUR 9,738 | CH-FDJP-CHE110141200 | Expenses - 190-1903-1-DE-CH-4 | |
| 2019-03-31 | Expenditure | EUR 2,530 | CH-FDJP-CHE110141200 | Expenses - 190-1903-1-SE-CH-4 | |
| 2019-03-31 | Expenditure | EUR 39 | CH-FDJP-CHE110141200 | Expenses - 190-1903-2-CH-GB-GOV-1 | |
| 2019-04-30 | Expenditure | EUR 18k | CH-FDJP-CHE110141200 | Expenses - 190-1904-1-CH-GB-GOV-1 | |
| 2019-04-30 | Expenditure | EUR 2,438 | CH-FDJP-CHE110141200 | Expenses - 190-1904-1-DE-GB-GOV-1 | |
| 2019-04-30 | Expenditure | EUR 14k | CH-FDJP-CHE110141200 | Expenses - 190-1904-1-FR-GB-GOV-1 | |
| 2019-05-31 | Expenditure | EUR 28k | CH-FDJP-CHE110141200 | Expenses - 190-1905-1-CH-GB-GOV-1 | |
| 2019-05-31 | Expenditure | EUR 7,300 | CH-FDJP-CHE110141200 | Expenses - 190-1905-1-DE-GB-GOV-1 | |
| 2019-06-30 | Expenditure | EUR 21k | CH-FDJP-CHE110141200 | Expenses - 190-1906-1-CH-GB-GOV-1 | |
| 2019-07-31 | Expenditure | EUR 23k | CH-FDJP-CHE110141200 | Expenses - 190-1907-1-CH-GB-GOV-1 | |
| 2019-07-31 | Expenditure | EUR 22k | CH-FDJP-CHE110141200 | Expenses - 190-1907-1-FR-GB-GOV-1 | |
| 2019-07-31 | Expenditure | EUR 3,250 | CH-FDJP-CHE110141200 | Expenses - 190-1907-1-SE-GB-GOV-1 | |
| 2019-08-31 | Expenditure | EUR 853 | CH-FDJP-CHE110141200 | Expenses - 190-1908-1-CH-FR-3 | |
| 2019-08-31 | Expenditure | EUR 21k | CH-FDJP-CHE110141200 | Expenses - 190-1908-1-CH-GB-GOV-1 | |
| 2019-09-30 | Expenditure | EUR 4,312 | CH-FDJP-CHE110141200 | Expenses - 190-1909-1-CH-FR-3 | |
| 2019-09-30 | Expenditure | EUR 4,438 | CH-FDJP-CHE110141200 | Expenses - 190-1909-1-CH-GB-GOV-1 | |
| 2019-09-30 | Expenditure | EUR 17k | CH-FDJP-CHE110141200 | Expenses - 190-1909-1-FR-GB-GOV-1 | |
| 2019-09-30 | Expenditure | EUR 15k | CH-FDJP-CHE110141200 | Expenses - 190-1909-2-CH-GB-GOV-1 | |
| 2019-10-31 | Expenditure | EUR 4,272 | CH-FDJP-CHE110141200 | Expenses - 190-1910-1-CH-FR-3 | |
| 2019-10-31 | Expenditure | EUR 3,104 | CH-FDJP-CHE110141200 | Expenses - 190-1910-1-CH-GB-GOV-1 | |
| 2019-10-31 | Expenditure | EUR 16k | CH-FDJP-CHE110141200 | Expenses - 190-1910-1-FR-FR-3 | |
| 2019-10-31 | Expenditure | EUR 1,610 | CH-FDJP-CHE110141200 | Expenses - 190-1910-1-SE-GB-GOV-1 | |
| 2019-10-31 | Expenditure | EUR 15k | CH-FDJP-CHE110141200 | Expenses - 190-1910-2-CH-GB-GOV-1 | |
| 2019-10-31 | Expenditure | EUR 25k | CH-FDJP-CHE110141200 | Expenses - 190-1910-2-FR | |
| 2019-10-31 | Expenditure | EUR 23k | CH-FDJP-CHE110141200 | Expenses - 190-1910-3-FR-GB-GOV-1 | |
| 2019-11-30 | Expenditure | EUR 28k | CH-FDJP-CHE110141200 | Expenses - 190-1911-1-CH-FR-3 | |
| 2019-11-30 | Expenditure | EUR 2,595 | CH-FDJP-CHE110141200 | Expenses - 190-1911-1-CH-GB-GOV-1 | |
| 2019-11-30 | Expenditure | EUR 5,785 | CH-FDJP-CHE110141200 | Expenses - 190-1911-1-FR | |
| 2019-11-30 | Expenditure | EUR 3,428 | CH-FDJP-CHE110141200 | Expenses - 190-1911-2-CH-GB-GOV-1 | |
| 2019-12-31 | Expenditure | EUR 20k | CH-FDJP-CHE110141200 | Expenses - 190-1912-1-CH-FR-3 | |
| 2019-12-31 | Expenditure | EUR 18k | CH-FDJP-CHE110141200 | Expenses - 190-1912-1-CH-GB-GOV-1 | |
| 2019-12-31 | Expenditure | EUR 5,672 | CH-FDJP-CHE110141200 | Expenses - 190-1912-1-FR-GB-GOV-1 | |
| 2019-12-31 | Expenditure | EUR 2,748 | CH-FDJP-CHE110141200 | Expenses - 190-1912-1-GB-GB-GOV-1 | |
| 2019-12-31 | Expenditure | EUR 33k | CH-FDJP-CHE110141200 | Expenses - 190-1912-2-CH-GB-GOV-1 | |
| 2020-01-31 | Expenditure | EUR 7,485 | Drugs for Neglected Diseases initiative | Expenses - 190-2001-1-CH-GB-GOV-1 | |
| 2020-01-31 | Expenditure | EUR 1,110 | Drugs for Neglected Diseases initiative | Expenses - 190-2001-1-FR-GB-GOV-1 | |
| 2020-01-31 | Expenditure | EUR 98 | Drugs for Neglected Diseases initiative | Expenses - 190-2001-1-US-GB-GOV-1 | |
| 2020-02-29 | Expenditure | EUR 13k | Drugs for Neglected Diseases initiative | Expenses - 190-2002-1-CH-FR-3 | |
| 2020-02-29 | Expenditure | EUR 27k | Drugs for Neglected Diseases initiative | Expenses - 190-2002-2-CH-GB-GOV-1 | |
| 2020-02-29 | Expenditure | EUR 2,500 | Drugs for Neglected Diseases initiative | Expenses - 190-2002-1-DE-GB-GOV-1 | |
| 2020-02-29 | Expenditure | EUR 3,763 | Drugs for Neglected Diseases initiative | Expenses - 190-2002-1-FR-GB-GOV-1 | |
| 2020-02-29 | Expenditure | EUR 301 | Drugs for Neglected Diseases initiative | Expenses - 190-2002-1-GB | |
| 2020-02-29 | Expenditure | EUR 292 | Drugs for Neglected Diseases initiative | Expenses - 190-2002-1-IN-GB-GOV-1 | |
| 2020-03-31 | Expenditure | EUR 9,807 | Drugs for Neglected Diseases initiative | Expenses - 190-2003-1-CH | |
| 2020-03-31 | Expenditure | EUR 3,588 | Drugs for Neglected Diseases initiative | Expenses - 190-2003-2-CH | |
| 2020-03-31 | Expenditure | EUR 25k | Drugs for Neglected Diseases initiative | Expenses - 190-2003-3-CH-GB-GOV-1 | |
| 2020-03-31 | Expenditure | EUR 22k | Drugs for Neglected Diseases initiative | Expenses - 190-2003-1-FR-GB-GOV-1 | |
| 2020-03-31 | Expenditure | EUR 486 | Drugs for Neglected Diseases initiative | Expenses - 190-2003-1-GB | |
| 2020-04-30 | Expenditure | EUR 7,633 | Drugs for Neglected Diseases initiative | Expenses - 190-2004-1-BR-GB-GOV-1 | |
| 2020-04-30 | Expenditure | EUR 15k | Drugs for Neglected Diseases initiative | Expenses - 190-2004-1-CH-FR-3 | |
| 2020-04-30 | Expenditure | EUR 13k | Drugs for Neglected Diseases initiative | Expenses - 190-2004-2-CH | |
| 2020-04-30 | Expenditure | EUR 23k | Drugs for Neglected Diseases initiative | Expenses - 190-2004-3-CH-GB-GOV-1 | |
| 2020-04-30 | Expenditure | EUR 2,369 | Drugs for Neglected Diseases initiative | Expenses - 190-2004-1-DE-GB-GOV-1 | |
| 2020-05-31 | Expenditure | EUR 15k | Drugs for Neglected Diseases initiative | Expenses - 190-2005-1-CH-FR-3 | |
| 2020-05-31 | Expenditure | EUR 13k | Drugs for Neglected Diseases initiative | Expenses - 190-2005-2-CH | |
| 2020-05-31 | Expenditure | EUR 25k | Drugs for Neglected Diseases initiative | Expenses - 190-2005-3-CH-GB-GOV-1 | |
| 2020-05-31 | Expenditure | EUR 11k | Drugs for Neglected Diseases initiative | Expenses - 190-2005-1-FR-GB-GOV-1 | |
| 2020-06-30 | Expenditure | EUR 15k | Drugs for Neglected Diseases initiative | Expenses - 190-2006-1-CH-FR-3 | |
| 2020-06-30 | Expenditure | EUR 3,416 | Drugs for Neglected Diseases initiative | Expenses - 190-2006-2-CH | |
| 2020-06-30 | Expenditure | EUR 10k | Drugs for Neglected Diseases initiative | Expenses - 190-2006-3-CH | |
| 2020-06-30 | Expenditure | EUR 21k | Drugs for Neglected Diseases initiative | Expenses - 190-2006-4-CH-GB-GOV-1 | |
| 2020-07-31 | Expenditure | EUR 15k | Drugs for Neglected Diseases initiative | Expenses - 190-2007-1-CH-FR-3 | |
| 2020-07-31 | Expenditure | EUR 18k | Drugs for Neglected Diseases initiative | Expenses - 190-2007-2-CH-GB-GOV-1 | |
| 2020-07-31 | Expenditure | EUR 2,500 | Drugs for Neglected Diseases initiative | Expenses - 190-2007-1-DE-GB-GOV-1 | |
| 2020-07-31 | Expenditure | EUR 556 | Drugs for Neglected Diseases initiative | Expenses - 190-2007-1-FR-GB-GOV-1 | |
| 2020-08-31 | Expenditure | EUR 20k | Drugs for Neglected Diseases initiative | Expenses - 190-2008-1-CH-GB-GOV-1 | |
| 2020-09-30 | Expenditure | EUR 26k | Drugs for Neglected Diseases initiative | Expenses - 190-2009-1-CH-GB-GOV-1 | |
| 2020-10-31 | Expenditure | EUR 24k | Drugs for Neglected Diseases initiative | Expenses - 190-2010-1-CH-GB-GOV-1 | |
| 2020-10-31 | Expenditure | EUR 17k | Drugs for Neglected Diseases initiative | Expenses - 190-2010-1-FR | |
| 2020-10-31 | Expenditure | EUR 6,771 | Drugs for Neglected Diseases initiative | Expenses - 190-2010-2-FR-GB-GOV-1 | |
| 2020-11-30 | Expenditure | EUR 8,989 | Drugs for Neglected Diseases initiative | Expenses - 190-2011-1-CH | |
| 2020-11-30 | Expenditure | EUR 19k | Drugs for Neglected Diseases initiative | Expenses - 190-2011-2-CH-GB-GOV-1 | |
| 2020-11-30 | Expenditure | EUR 1,042 | Drugs for Neglected Diseases initiative | Expenses - 190-2011-1-GB-GB-GOV-1 | |
| 2020-11-30 | Expenditure | EUR 4,809 | Drugs for Neglected Diseases initiative | Expenses - 190-2011-1-KE-GB-GOV-1 | |
| 2020-11-30 | Expenditure | EUR 124 | Drugs for Neglected Diseases initiative | Expenses - 190-2011-1-US-GB-GOV-1 | |
| 2020-12-31 | Expenditure | EUR 2,730 | Drugs for Neglected Diseases initiative | Expenses - 190-2012-1-CH-FR-3 | |
| 2020-12-31 | Expenditure | EUR 8,954 | Drugs for Neglected Diseases initiative | Expenses - 190-2012-2-CH | |
| 2020-12-31 | Expenditure | EUR 38k | Drugs for Neglected Diseases initiative | Expenses - 190-2012-3-CH-GB-GOV-1 | |
| 2020-12-31 | Expenditure | EUR 534 | Drugs for Neglected Diseases initiative | Expenses - 190-2012-1-GB | |
| 2020-12-31 | Expenditure | EUR 2,334 | Drugs for Neglected Diseases initiative | Expenses - 190-2012-2-GB-GB-GOV-1 | |
| 2020-12-31 | Expenditure | EUR 42k | Drugs for Neglected Diseases initiative | Expenses - 190-2012-1-US | |
| 2021-10-31 | Expenditure | EUR 8,512 | Drugs for Neglected Diseases initiative | Expenses - 190-2110-1-CH-FR-3 | |
| 2021-10-31 | Expenditure | EUR 7,439 | Drugs for Neglected Diseases initiative | Expenses - 190-2110-2-CH | |
| 2021-10-31 | Expenditure | EUR 5,931 | Drugs for Neglected Diseases initiative | Expenses - 190-2110-3-CH-GB-GOV-1 | |
| 2021-10-31 | Expenditure | EUR 8,049 | Drugs for Neglected Diseases initiative | Expenses - 190-2110-4-CH-XM-DAC-928 | |
| 2021-10-31 | Expenditure | EUR 1,856 | Drugs for Neglected Diseases initiative | Expenses - 190-2110-5-CH | |
| 2021-10-31 | Expenditure | EUR 345 | Drugs for Neglected Diseases initiative | Expenses - 190-2110-1-FR-FR-3 | |
| 2021-10-31 | Expenditure | EUR 2,860 | Drugs for Neglected Diseases initiative | Expenses - 190-2110-2-FR-GB-GOV-1 | |
| 2021-10-31 | Expenditure | EUR 6,627 | Drugs for Neglected Diseases initiative | Expenses - 190-2110-3-FR | |
| 2021-10-31 | Expenditure | EUR 2,025 | Drugs for Neglected Diseases initiative | Expenses - 190-2110-1-US-GB-GOV-1 | |
| 2021-01-31 | Expenditure | EUR -1,392 | Drugs for Neglected Diseases initiative | Expenses - 190-2101-1-CH-FR-3 | |
| 2021-01-31 | Expenditure | EUR 27k | Drugs for Neglected Diseases initiative | Expenses - 190-2101-2-CH-GB-GOV-1 | |
| 2021-01-31 | Expenditure | EUR 13k | Drugs for Neglected Diseases initiative | Expenses - 190-2101-3-CH-US-EIN-27-1414646 | |
| 2021-01-31 | Expenditure | EUR 1,283 | Drugs for Neglected Diseases initiative | Expenses - 190-2101-4-CH-XM-DAC-928 | |
| 2021-01-31 | Expenditure | EUR 1,690 | Drugs for Neglected Diseases initiative | Expenses - 190-2101-5-CH | |
| 2021-01-31 | Expenditure | EUR 2,662 | Drugs for Neglected Diseases initiative | Expenses - 190-2101-1-FR-FR-3 | |
| 2021-01-31 | Expenditure | EUR 30 | Drugs for Neglected Diseases initiative | Expenses - 190-2101-1-US | |
| 2021-01-31 | Expenditure | EUR 1 | Drugs for Neglected Diseases initiative | Expenses - 190-2101-2-US-CH-4 | |
| 2021-01-31 | Expenditure | EUR 1,990 | Drugs for Neglected Diseases initiative | Expenses - 190-2101-3-US-GB-GOV-1 | |
| 2021-02-28 | Expenditure | EUR 1,300 | Drugs for Neglected Diseases initiative | Expenses - 190-2102-1-BR-GB-GOV-1 | |
| 2021-02-28 | Expenditure | EUR -1,339 | Drugs for Neglected Diseases initiative | Expenses - 190-2102-1-CH-FR-3 | |
| 2021-02-28 | Expenditure | EUR 33k | Drugs for Neglected Diseases initiative | Expenses - 190-2102-2-CH-GB-GOV-1 | |
| 2021-02-28 | Expenditure | EUR 6,306 | Drugs for Neglected Diseases initiative | Expenses - 190-2102-1-GB-US-EIN-27-1414646 | |
| 2021-02-28 | Expenditure | EUR 8 | Drugs for Neglected Diseases initiative | Expenses - 190-2102-1-US | |
| 2021-02-28 | Expenditure | EUR 2,313 | Drugs for Neglected Diseases initiative | Expenses - 190-2102-2-US-GB-GOV-1 | |
| 2021-03-31 | Expenditure | EUR 5,778 | Drugs for Neglected Diseases initiative | Expenses - 190-2103-1-CH-FR-3 | |
| 2021-03-31 | Expenditure | EUR 4,834 | Drugs for Neglected Diseases initiative | Expenses - 190-2103-2-CH-CH-4 | |
| 2021-03-31 | Expenditure | EUR 20k | Drugs for Neglected Diseases initiative | Expenses - 190-2103-3-CH-GB-GOV-1 | |
| 2021-03-31 | Expenditure | EUR 6,500 | Drugs for Neglected Diseases initiative | Expenses - 190-2103-4-CH-US-EIN-27-1414646 | |
| 2021-03-31 | Expenditure | EUR 6,067 | Drugs for Neglected Diseases initiative | Expenses - 190-2103-1-IN-GB-GOV-1 | |
| 2021-03-31 | Expenditure | EUR 7 | Drugs for Neglected Diseases initiative | Expenses - 190-2103-1-US | |
| 2021-03-31 | Expenditure | EUR 1 | Drugs for Neglected Diseases initiative | Expenses - 190-2103-2-US-CH-4 | |
| 2021-03-31 | Expenditure | EUR 1,970 | Drugs for Neglected Diseases initiative | Expenses - 190-2103-3-US-GB-GOV-1 | |
| 2021-04-30 | Expenditure | EUR 5,465 | Drugs for Neglected Diseases initiative | Expenses - 190-2104-1-CH-FR-3 | |
| 2021-04-30 | Expenditure | EUR 7,309 | Drugs for Neglected Diseases initiative | Expenses - 190-2104-2-CH-GB-GOV-1 | |
| 2021-04-30 | Expenditure | EUR 5,465 | Drugs for Neglected Diseases initiative | Expenses - 190-2104-3-CH-US-EIN-27-1414646 | |
| 2021-04-30 | Expenditure | EUR 9,148 | Drugs for Neglected Diseases initiative | Expenses - 190-2104-4-CH | |
| 2021-04-30 | Expenditure | EUR 2,000 | Drugs for Neglected Diseases initiative | Expenses - 190-2104-1-US | |
| 2021-04-30 | Expenditure | EUR 7 | Drugs for Neglected Diseases initiative | Expenses - 190-2104-2-US-GB-GOV-1 | |
| 2021-05-31 | Expenditure | EUR 47 | Drugs for Neglected Diseases initiative | Expenses - 190-2105-1-BR | |
| 2021-05-31 | Expenditure | EUR 5,480 | Drugs for Neglected Diseases initiative | Expenses - 190-2105-1-CH-FR-3 | |
| 2021-05-31 | Expenditure | EUR 16k | Drugs for Neglected Diseases initiative | Expenses - 190-2105-2-CH-GB-GOV-1 | |
| 2021-05-31 | Expenditure | EUR 5,480 | Drugs for Neglected Diseases initiative | Expenses - 190-2105-3-CH-US-EIN-27-1414646 | |
| 2021-05-31 | Expenditure | EUR 197 | Drugs for Neglected Diseases initiative | Expenses - 190-2105-4-CH | |
| 2021-05-31 | Expenditure | EUR 4,768 | Drugs for Neglected Diseases initiative | Expenses - 190-2105-1-GB-US-EIN-27-1414646 | |
| 2021-05-31 | Expenditure | EUR 1,958 | Drugs for Neglected Diseases initiative | Expenses - 190-2105-1-US | |
| 2021-05-31 | Expenditure | EUR 18k | Drugs for Neglected Diseases initiative | Expenses - 190-2105-2-US-CH-4 | |
| 2021-05-31 | Expenditure | EUR -10 | Drugs for Neglected Diseases initiative | Expenses - 190-2105-3-US-GB-GOV-1 | |
| 2021-06-30 | Expenditure | EUR 267 | Drugs for Neglected Diseases initiative | Expenses - 190-2106-1-BR-GB-GOV-1 | |
| 2021-06-30 | Expenditure | EUR 5,514 | Drugs for Neglected Diseases initiative | Expenses - 190-2106-1-CH-FR-3 | |
| 2021-06-30 | Expenditure | EUR 19k | Drugs for Neglected Diseases initiative | Expenses - 190-2106-2-CH-GB-GOV-1 | |
| 2021-06-30 | Expenditure | EUR 6,164 | Drugs for Neglected Diseases initiative | Expenses - 190-2106-3-CH-US-EIN-27-1414646 | |
| 2021-11-30 | Expenditure | EUR 12k | Drugs for Neglected Diseases initiative | Expenses - 190-2111-1-CH-FR-3 | |
| 2021-11-30 | Expenditure | EUR 3,772 | Drugs for Neglected Diseases initiative | Expenses - 190-2111-2-CH | |
| 2021-11-30 | Expenditure | EUR 6,729 | Drugs for Neglected Diseases initiative | Expenses - 190-2111-3-CH-GB-GOV-1 | |
| 2021-11-30 | Expenditure | EUR 8,163 | Drugs for Neglected Diseases initiative | Expenses - 190-2111-4-CH-XM-DAC-928 | |
| 2021-11-30 | Expenditure | EUR 1,883 | Drugs for Neglected Diseases initiative | Expenses - 190-2111-5-CH | |
| 2021-11-30 | Expenditure | EUR 3,500 | Drugs for Neglected Diseases initiative | Expenses - 190-2111-1-FR-GB-GOV-1 | |
| 2021-11-30 | Expenditure | EUR 3,078 | Drugs for Neglected Diseases initiative | Expenses - 190-2111-1-US-GB-GOV-1 | |
| 2021-12-31 | Expenditure | EUR 33k | Drugs for Neglected Diseases initiative | Expenses - 190-2112-1-CH-FR-3 | |
| 2021-12-31 | Expenditure | EUR 10k | Drugs for Neglected Diseases initiative | Expenses - 190-2112-2-CH | |
| 2021-12-31 | Expenditure | EUR 41k | Drugs for Neglected Diseases initiative | Expenses - 190-2112-3-CH-GB-GOV-1 | |
| 2021-12-31 | Expenditure | EUR 18k | Drugs for Neglected Diseases initiative | Expenses - 190-2112-4-CH-XM-DAC-928 | |
| 2021-12-31 | Expenditure | EUR 6,534 | Drugs for Neglected Diseases initiative | Expenses - 190-2112-5-CH | |
| 2021-12-31 | Expenditure | EUR 3,993 | Drugs for Neglected Diseases initiative | Expenses - 190-2112-1-FR-FR-3 | |
| 2021-12-31 | Expenditure | EUR 3,470 | Drugs for Neglected Diseases initiative | Expenses - 190-2112-2-FR-GB-GOV-1 | |
| 2021-12-31 | Expenditure | EUR 1,177 | Drugs for Neglected Diseases initiative | Expenses - 190-2112-1-KR-GB-GOV-1 | |
| 2021-06-30 | Expenditure | EUR 9,595 | Drugs for Neglected Diseases initiative | Expenses - 190-2106-4-CH | |
| 2021-06-30 | Expenditure | EUR 2,357 | Drugs for Neglected Diseases initiative | Expenses - 190-2106-1-GB-US-EIN-27-1414646 | |
| 2021-06-30 | Expenditure | EUR 2,931 | Drugs for Neglected Diseases initiative | Expenses - 190-2106-1-US | |
| 2021-06-30 | Expenditure | EUR 13 | Drugs for Neglected Diseases initiative | Expenses - 190-2106-2-US-GB-GOV-1 | |
| 2021-07-31 | Expenditure | EUR 5,529 | Drugs for Neglected Diseases initiative | Expenses - 190-2107-1-CH-FR-3 | |
| 2021-07-31 | Expenditure | EUR 15k | Drugs for Neglected Diseases initiative | Expenses - 190-2107-2-CH-GB-GOV-1 | |
| 2021-07-31 | Expenditure | EUR 5,529 | Drugs for Neglected Diseases initiative | Expenses - 190-2107-3-CH-US-EIN-27-1414646 | |
| 2021-07-31 | Expenditure | EUR 1,162 | Drugs for Neglected Diseases initiative | Expenses - 190-2107-1-FR | |
| 2021-07-31 | Expenditure | EUR 1,978 | Drugs for Neglected Diseases initiative | Expenses - 190-2107-1-US | |
| 2021-08-31 | Expenditure | EUR 5,573 | Drugs for Neglected Diseases initiative | Expenses - 190-2108-1-CH-FR-3 | |
| 2021-08-31 | Expenditure | EUR 13k | Drugs for Neglected Diseases initiative | Expenses - 190-2108-2-CH-GB-GOV-1 | |
| 2021-08-31 | Expenditure | EUR 9,750 | Drugs for Neglected Diseases initiative | Expenses - 190-2108-3-CH-US-EIN-27-1414646 | |
| 2021-08-31 | Expenditure | EUR 7,291 | Drugs for Neglected Diseases initiative | Expenses - 190-2108-4-CH-XM-DAC-928 | |
| 2021-08-31 | Expenditure | EUR 2,199 | Drugs for Neglected Diseases initiative | Expenses - 190-2108-1-FR | |
| 2021-08-31 | Expenditure | EUR 2,016 | Drugs for Neglected Diseases initiative | Expenses - 190-2108-1-US | |
| 2021-08-31 | Expenditure | EUR 13k | Drugs for Neglected Diseases initiative | Expenses - 190-2108-2-US-GB-GOV-1 | |
| 2021-09-30 | Expenditure | EUR 5,618 | Drugs for Neglected Diseases initiative | Expenses - 190-2109-1-CH-FR-3 | |
| 2021-09-30 | Expenditure | EUR 25k | Drugs for Neglected Diseases initiative | Expenses - 190-2109-2-CH-GB-GOV-1 | |
| 2021-09-30 | Expenditure | EUR 12k | Drugs for Neglected Diseases initiative | Expenses - 190-2109-3-CH-XM-DAC-928 | |
| 2021-09-30 | Expenditure | EUR 18k | Drugs for Neglected Diseases initiative | Expenses - 190-2109-4-CH | |
| 2021-09-30 | Expenditure | EUR 375 | Drugs for Neglected Diseases initiative | Expenses - 190-2109-1-FR-FR-3 | |
| 2021-09-30 | Expenditure | EUR 6,035 | Drugs for Neglected Diseases initiative | Expenses - 190-2109-2-FR-GB-GOV-1 | |
| 2021-09-30 | Expenditure | EUR 3,569 | Drugs for Neglected Diseases initiative | Expenses - 190-2109-3-FR | |
| 2021-12-31 | Expenditure | EUR 3,492 | Drugs for Neglected Diseases initiative | Expenses - 190-2112-1-US-GB-GOV-1 | |
| 2023-01-31 | Expenditure | EUR -351 | Drugs for Neglected Diseases initiative | Expenses - 190-2301-1-CH | |
| 2023-01-31 | Expenditure | EUR 3,161 | Drugs for Neglected Diseases initiative | Expenses - 190-2301-2-CH-FR-3 | |
| 2023-01-31 | Expenditure | EUR 903 | Drugs for Neglected Diseases initiative | Expenses - 190-2301-3-CH | |
| 2023-01-31 | Expenditure | EUR 18k | Drugs for Neglected Diseases initiative | Expenses - 190-2301-4-CH-CH-4 | |
| 2023-01-31 | Expenditure | EUR 5,822 | Drugs for Neglected Diseases initiative | Expenses - 190-2301-5-CH-GB-GOV-1 | |
| 2023-01-31 | Expenditure | EUR 6,626 | Drugs for Neglected Diseases initiative | Expenses - 190-2301-1-KE | |
| 2023-01-31 | Expenditure | EUR 3,433 | Drugs for Neglected Diseases initiative | Expenses - 190-2301-2-KE-CH-4 | |
| 2023-01-31 | Expenditure | EUR 3,235 | Drugs for Neglected Diseases initiative | Expenses - 190-2301-1-US-GB-GOV-1 | |
| 2023-02-28 | Expenditure | EUR 975 | Drugs for Neglected Diseases initiative | Expenses - 190-2302-1-CD-CH-4 | |
| 2023-02-28 | Expenditure | EUR 1,587 | Drugs for Neglected Diseases initiative | Expenses - 190-2302-1-CH-41143 | |
| 2023-02-28 | Expenditure | EUR 3,132 | Drugs for Neglected Diseases initiative | Expenses - 190-2302-2-CH-FR-3 | |
| 2023-02-28 | Expenditure | EUR 17k | Drugs for Neglected Diseases initiative | Expenses - 190-2302-3-CH-CH-4 | |
| 2023-02-28 | Expenditure | EUR 3,235 | Drugs for Neglected Diseases initiative | Expenses - 190-2302-4-CH-GB-GOV-1 | |
| 2023-02-28 | Expenditure | EUR 11k | Drugs for Neglected Diseases initiative | Expenses - 190-2302-1-KE | |
| 2023-02-28 | Expenditure | EUR 1,580 | Drugs for Neglected Diseases initiative | Expenses - 190-2302-2-KE-CH-4 | |
| 2023-02-28 | Expenditure | EUR 3,161 | Drugs for Neglected Diseases initiative | Expenses - 190-2302-1-US-GB-GOV-1 | |
| 2023-03-31 | Expenditure | EUR 7,634 | Drugs for Neglected Diseases initiative | Expenses - 190-2303-1-CH-FR-3 | |
| 2023-03-31 | Expenditure | EUR 12k | Drugs for Neglected Diseases initiative | Expenses - 190-2303-2-CH-XM-DAC-7 | |
| 2023-03-31 | Expenditure | EUR 21k | Drugs for Neglected Diseases initiative | Expenses - 190-2303-3-CH-CH-4 | |
| 2023-03-31 | Expenditure | EUR 404 | Drugs for Neglected Diseases initiative | Expenses - 190-2303-4-CH-GB-GOV-1 | |
| 2023-03-31 | Expenditure | EUR 7,280 | Drugs for Neglected Diseases initiative | Expenses - 190-2303-1-KE | |
| 2023-03-31 | Expenditure | EUR 2,922 | Drugs for Neglected Diseases initiative | Expenses - 190-2303-2-KE | |
| 2023-03-31 | Expenditure | EUR 794 | Drugs for Neglected Diseases initiative | Expenses - 190-2303-3-KE-CH-4 | |
| 2023-03-31 | Expenditure | EUR 3,265 | Drugs for Neglected Diseases initiative | Expenses - 190-2303-1-US-GB-GOV-1 | |
| 2023-04-30 | Expenditure | EUR 6,190 | Drugs for Neglected Diseases initiative | Expenses - 190-2304-1-CH-FR-3 | |
| 2023-04-30 | Expenditure | EUR 8,784 | Drugs for Neglected Diseases initiative | Expenses - 190-2304-2-CH | |
| 2023-04-30 | Expenditure | EUR 348 | Drugs for Neglected Diseases initiative | Expenses - 190-2304-3-CH | |
| 2023-04-30 | Expenditure | EUR 12k | Drugs for Neglected Diseases initiative | Expenses - 190-2304-4-CH-XM-DAC-7 | |
| 2023-04-30 | Expenditure | EUR 18k | Drugs for Neglected Diseases initiative | Expenses - 190-2304-5-CH-GB-GOV-1 | |
| 2023-04-30 | Expenditure | EUR 80 | Drugs for Neglected Diseases initiative | Expenses - 190-2304-1-FR-FR-3 | |
| 2023-04-30 | Expenditure | EUR 20 | Drugs for Neglected Diseases initiative | Expenses - 190-2304-1-IN-FR-3 | |
| 2023-04-30 | Expenditure | EUR 9,675 | Drugs for Neglected Diseases initiative | Expenses - 190-2304-1-KE | |
| 2023-04-30 | Expenditure | EUR 737 | Drugs for Neglected Diseases initiative | Expenses - 190-2304-2-KE-GB-GOV-1 | |
| 2023-04-30 | Expenditure | EUR 3,275 | Drugs for Neglected Diseases initiative | Expenses - 190-2304-1-US-FR-3 | |
| 2023-05-31 | Expenditure | EUR 2,030 | Drugs for Neglected Diseases initiative | Expenses - 190-2305-1-CH-41143 | |
| 2023-05-31 | Expenditure | EUR 14k | Drugs for Neglected Diseases initiative | Expenses - 190-2305-2-CH-FR-3 | |
| 2023-05-31 | Expenditure | EUR 18k | Drugs for Neglected Diseases initiative | Expenses - 190-2305-3-CH | |
| 2023-05-31 | Expenditure | EUR 9,634 | Drugs for Neglected Diseases initiative | Expenses - 190-2305-4-CH-XM-DAC-7 | |
| 2023-05-31 | Expenditure | EUR 26k | Drugs for Neglected Diseases initiative | Expenses - 190-2305-5-CH-GB-GOV-1 | |
| 2023-05-31 | Expenditure | EUR 3,277 | Drugs for Neglected Diseases initiative | Expenses - 190-2305-1-IN-FR-3 | |
| 2023-05-31 | Expenditure | EUR 9,129 | Drugs for Neglected Diseases initiative | Expenses - 190-2305-1-KE | |
| 2023-05-31 | Expenditure | EUR 1,866 | Drugs for Neglected Diseases initiative | Expenses - 190-2305-2-KE-FR-3 | |
| 2023-05-31 | Expenditure | EUR 632 | Drugs for Neglected Diseases initiative | Expenses - 190-2305-3-KE-GB-GOV-1 | |
| 2023-05-31 | Expenditure | EUR 3,199 | Drugs for Neglected Diseases initiative | Expenses - 190-2305-1-US-FR-3 | |
| 2023-06-30 | Expenditure | EUR 19k | Drugs for Neglected Diseases initiative | Expenses - 190-2306-1-CH-FR-3 | |
| 2023-06-30 | Expenditure | EUR 17k | Drugs for Neglected Diseases initiative | Expenses - 190-2306-2-CH | |
| 2023-06-30 | Expenditure | EUR 1,625 | Drugs for Neglected Diseases initiative | Expenses - 190-2306-3-CH-XM-DAC-7 | |
| 2023-06-30 | Expenditure | EUR 27k | Drugs for Neglected Diseases initiative | Expenses - 190-2306-4-CH-GB-GOV-1 | |
| 2023-06-30 | Expenditure | EUR 10k | Drugs for Neglected Diseases initiative | Expenses - 190-2306-1-KE | |
| 2023-06-30 | Expenditure | EUR 524 | Drugs for Neglected Diseases initiative | Expenses - 190-2306-2-KE | |
| 2023-06-30 | Expenditure | EUR 20 | Drugs for Neglected Diseases initiative | Expenses - 190-2306-3-KE | |
| 2023-06-30 | Expenditure | EUR 1,684 | Drugs for Neglected Diseases initiative | Expenses - 190-2306-4-KE-GB-GOV-1 | |
| 2023-06-30 | Expenditure | EUR 1,300 | Drugs for Neglected Diseases initiative | Expenses - 190-2306-1-NL | |
| 2023-06-30 | Expenditure | EUR 3,200 | Drugs for Neglected Diseases initiative | Expenses - 190-2306-1-US-GB-GOV-1 | |
| 2023-07-31 | Expenditure | EUR 16k | Drugs for Neglected Diseases initiative | Expenses - 190-2307-1-CH | |
| 2023-07-31 | Expenditure | EUR 2,994 | Drugs for Neglected Diseases initiative | Expenses - 190-2307-2-CH | |
| 2023-07-31 | Expenditure | EUR 1,622 | Drugs for Neglected Diseases initiative | Expenses - 190-2307-3-CH-XM-DAC-7 | |
| 2023-07-31 | Expenditure | EUR 43k | Drugs for Neglected Diseases initiative | Expenses - 190-2307-4-CH-GB-GOV-1 | |
| 2023-07-31 | Expenditure | EUR 525 | Drugs for Neglected Diseases initiative | Expenses - 190-2307-1-DE | |
| 2023-07-31 | Expenditure | EUR 88 | Drugs for Neglected Diseases initiative | Expenses - 190-2307-1-IN-GB-GOV-1 | |
| 2023-07-31 | Expenditure | EUR 4,250 | Drugs for Neglected Diseases initiative | Expenses - 190-2307-1-KE | |
| 2023-07-31 | Expenditure | EUR 6,642 | Drugs for Neglected Diseases initiative | Expenses - 190-2307-2-KE | |
| 2023-07-31 | Expenditure | EUR 40 | Drugs for Neglected Diseases initiative | Expenses - 190-2307-3-KE | |
| 2023-07-31 | Expenditure | EUR 1,876 | Drugs for Neglected Diseases initiative | Expenses - 190-2307-4-KE-GB-GOV-1 | |
| 2023-07-31 | Expenditure | EUR 3 | Drugs for Neglected Diseases initiative | Expenses - 190-2307-1-MY | |
| 2023-07-31 | Expenditure | EUR 241 | Drugs for Neglected Diseases initiative | Expenses - 190-2307-2-MY-GB-GOV-1 | |
| 2023-07-31 | Expenditure | EUR 3,267 | Drugs for Neglected Diseases initiative | Expenses - 190-2307-1-US-GB-GOV-1 | |
| 2023-08-31 | Expenditure | EUR 26k | Drugs for Neglected Diseases initiative | Expenses - 190-2308-1-CH | |
| 2023-08-31 | Expenditure | EUR 16k | Drugs for Neglected Diseases initiative | Expenses - 190-2308-2-CH | |
| 2023-08-31 | Expenditure | EUR 53 | Drugs for Neglected Diseases initiative | Expenses - 190-2308-3-CH | |
| 2023-08-31 | Expenditure | EUR 1,640 | Drugs for Neglected Diseases initiative | Expenses - 190-2308-4-CH-XM-DAC-7 | |
| 2023-08-31 | Expenditure | EUR 18k | Drugs for Neglected Diseases initiative | Expenses - 190-2308-5-CH-CH-4 | |
| 2023-08-31 | Expenditure | EUR 87 | Drugs for Neglected Diseases initiative | Expenses - 190-2308-1-GB | |
| 2023-08-31 | Expenditure | EUR 3,174 | Drugs for Neglected Diseases initiative | Expenses - 190-2308-1-KE | |
| 2023-08-31 | Expenditure | EUR 695 | Drugs for Neglected Diseases initiative | Expenses - 190-2308-2-KE | |
| 2023-08-31 | Expenditure | EUR 5,985 | Drugs for Neglected Diseases initiative | Expenses - 190-2308-3-KE | |
| 2023-08-31 | Expenditure | EUR 1,486 | Drugs for Neglected Diseases initiative | Expenses - 190-2308-4-KE-CH-4 | |
| 2023-08-31 | Expenditure | EUR 238 | Drugs for Neglected Diseases initiative | Expenses - 190-2308-1-MY-CH-4 | |
| 2023-08-31 | Expenditure | EUR 2,724 | Drugs for Neglected Diseases initiative | Expenses - 190-2308-1-US-CH-4 |
Showing 300 of 545. The API returns all of them.
Struck-through rows were in the previous version, last seen 2026-10-02 02:19 UTC, and are not in the current file.